> top > docs > PubMed:10805756 > annotations
TextAE configuration unavailable!

PubMed:10805756 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-gro-2013-training

Id Subject Object Predicate Lexical cue
T2 19-23 TranscriptionFactor denotes SOX9
T3 27-37 SecondMessenger denotes cyclic AMP
T4 48-64 Enzyme denotes protein kinase A
T6 74-80 TranscriptionFactor denotes SOX9's
T8 108-114 Gene denotes Col2a1
T9 115-126 Cell denotes chondrocyte
T10 136-144 Enhancer denotes enhancer
T11 146-150 TranscriptionFactor denotes Sox9
T16 324-340 Protein denotes Son of Sevenless
T18 371-382 Cell denotes chondrocyte
T19 383-395 DNA denotes cDNA library
T20 425-432 ProteinSubunit denotes subunit
T22 448-452 SecondMessenger denotes cAMP
T23 464-480 Enzyme denotes protein kinase A
T24 482-492 Enzyme denotes PKA-Calpha
T26 523-527 TranscriptionFactor denotes SOX9
T27 562-565 Enzyme denotes PKA
T29 582-587 AminoAcid denotes sites
T30 595-599 TranscriptionFactor denotes SOX9
T32 627-630 Enzyme denotes PKA
T33 649-653 TranscriptionFactor denotes SOX9
T35 681-691 Enzyme denotes PKA-Calpha
T36 704-715 Cell denotes COS-7 cells
T37 735-745 Enzyme denotes PKA-Calpha
T38 750-754 TranscriptionFactor denotes SOX9
T40 766-774 DNA denotes plasmids
T41 776-779 Enzyme denotes PKA
T44 812-826 TranscriptionFactor denotes wild-type SOX9
T45 1018-1022 TranscriptionFactor denotes SOX9
T47 1041-1051 AminoAcid denotes serine 211
T48 1068-1071 Enzyme denotes PKA
T50 1088-1093 AminoAcid denotes sites
T51 1128-1132 SecondMessenger denotes cAMP
T52 1136-1148 Cell denotes chondrocytes
T55 1202-1206 TranscriptionFactor denotes Sox9
T56 1245-1250 Eukaryote denotes mouse
T57 1251-1267 Tissue denotes embryo hind legs
T58 1280-1284 TranscriptionFactor denotes Sox9
T60 1303-1313 AminoAcid denotes serine 211
T62 1347-1367 CellComponent denotes prehypertrophic zone
T67 1502-1506 SecondMessenger denotes cAMP
T69 1561-1565 MessengerRNA denotes mRNA
T70 1576-1582 Protein denotes Col2a1
T71 1593-1609 MolecularEntity denotes specific markers
T73 1675-1678 Enzyme denotes PKA
T76 1726-1730 TranscriptionFactor denotes SOX9
T77 1744-1756 SecondMessenger denotes 8-bromo-cAMP
T78 1760-1772 Cell denotes chondrocytes
T80 1836-1840 TranscriptionFactor denotes SOX9
T81 1857-1863 Gene denotes Col2a1
T82 1864-1875 Cell denotes chondrocyte
T83 1885-1893 Enhancer denotes enhancer
T84 1924-1934 Enzyme denotes PKA-Calpha
T86 1961-1974 Enhancer denotes this enhancer
T88 1997-2000 Enzyme denotes PKA
T90 2027-2032 AminoAcid denotes sites
T91 2036-2040 TranscriptionFactor denotes SOX9
T93 2064-2074 Enzyme denotes PKA-Calpha
T95 2089-2102 Enhancer denotes this enhancer
T96 2106-2110 TranscriptionFactor denotes SOX9
T97 2112-2115 Enzyme denotes PKA
T99 2196-2200 Protein denotes SOX9
T100 2219-2226 Nucleus denotes nuclear
T103 2269-2273 TranscriptionFactor denotes SOX9
T104 2277-2280 Enzyme denotes PKA
T105 2308-2311 DNA denotes DNA
T107 2338-2342 TranscriptionFactor denotes SOX9
T108 2358-2362 SecondMessenger denotes cAMP
T111 2401-2405 TranscriptionFactor denotes SOX9
T112 2409-2412 Enzyme denotes PKA
T114 2422-2425 TranscriptionFactor denotes its
T116 2446-2449 DNA denotes DNA
T118 2476-2481 Peptide denotes PTHrP
T121 2507-2511 SecondMessenger denotes cAMP
T122 2553-2557 TranscriptionFactor denotes Sox9
T123 2573-2578 Peptide denotes PTHrP
T125 2596-2608 Tissue denotes growth plate
T127 2632-2640 TranscriptionFactorActivity denotes activity
T128 2644-2648 TranscriptionFactor denotes Sox9
T130 2677-2682 Peptide denotes PTHrP
T132 2702-2707 Cell denotes cells
T133 2711-2739 Cell denotes nonhypertrophic chondrocytes
T7 81-105 TranscriptionActivatorActivity denotes ability to transactivate
T12 156-214 HMGTF denotes high-mobility-group domain-containing transcription factor
T13 342-345 Protein denotes SOS
T134 415-424 CatalyticActivity denotes catalytic
T21 436-446 SecondMessenger denotes cyclic AMP
T136 867-879 TranscriptionFactor denotes SOX9 protein
T137 897-922 AminoAcid denotes PKA phosphorylation sites
T138 924-929 AminoAcid denotes S(64)
T139 934-940 AminoAcid denotes S(211)
T64 1442-1477 Peptide denotes parathyroid hormone-related peptide
T65 1479-1484 Peptide denotes PTHrP
T66 1486-1494 Protein denotes receptor
T141 1714-1722 TranscriptionFactorActivity denotes activity
T145 2167-2170 Enzyme denotes PKA
T147 2187-2192 AminoAcid denotes sites
T115 2426-2441 TranscriptionFactorActivity denotes transcriptional
E1 0-15 Phosphorylation denotes Phosphorylation
E2 65-73 Increase denotes enhances
E4 228-255 CellDifferentiation denotes chondrocyte differentiation
E5 260-279 DevelopmentalProcess denotes cartilage formation
E6 347-358 Transport denotes recruitment
E7 494-504 BindingToProtein denotes interacted
E8 566-581 Phosphorylation denotes phosphorylation
E9 609-623 Phosphorylation denotes phosphorylated
E10 663-677 Phosphorylation denotes phosphorylated
E11 755-765 GeneExpression denotes expression
E12 780-788 Increase denotes enhanced
E13 793-808 Phosphorylation denotes phosphorylation
E14 1023-1037 Phosphorylation denotes phosphorylated
E15 1072-1087 Phosphorylation denotes phosphorylation
E16 1158-1167 Increase denotes increased
E17 1172-1187 Phosphorylation denotes phosphorylation
E18 1285-1299 Phosphorylation denotes phosphorylated
E19 1330-1339 Localization denotes localized
E20 1424-1434 GeneExpression denotes expression
E21 1548-1556 Increase denotes increase
E22 1613-1640 CellDifferentiation denotes chondrocyte differentiation
E23 1679-1694 Phosphorylation denotes phosphorylation
E24 1701-1709 RegulatoryProcess denotes modulate
E25 1784-1793 Increase denotes increased
E26 1935-1944 Increase denotes increased
E27 1976-1985 Mutation denotes Mutations
E28 2001-2016 Phosphorylation denotes phosphorylation
E29 2050-2059 Decrease denotes decreased
E30 2075-2085 PositiveRegulation denotes activation
E31 2116-2131 Phosphorylation denotes phosphorylation
E32 2227-2239 Localization denotes localization
E33 2250-2265 Phosphorylation denotes phosphorylation
E34 2312-2319 BindingOfTranscriptionFactorToDNA denotes binding
E35 2363-2372 SignalingPathway denotes signaling
E36 2382-2397 Phosphorylation denotes phosphorylation
E37 2413-2421 Increase denotes enhances
E39 2450-2457 BindingOfTranscriptionFactorToDNA denotes binding
E40 2482-2491 SignalingPathway denotes signaling
E41 2495-2503 RegulatoryProcess denotes mediated
E42 2579-2588 SignalingPathway denotes signaling
E43 2622-2631 Increase denotes increased
E44 2655-2662 RegulatoryProcess denotes mediate
E45 2686-2697 Maintenance denotes maintaining
E3 846-861 Phosphorylation denotes phosphorylation
E46 947-954 Mutation denotes mutated
E47 1798-1806 Transcription denotes activity
E48 1949-1957 Transcription denotes activity
E49 2140-2149 Mutation denotes mutations
E50 2171-2186 Phosphorylation denotes phosphorylation
E38 1548-1556 Increase denotes increase
E51 2075-2085 PositiveRegulation denotes activation
E52 2413-2421 Increase denotes enhances
E53 2050-2059 Decrease denotes decreased
R1 T8 T10 hasPart Col2a1,enhancer
R2 T10 T9 locatedIn enhancer,chondrocyte
R4 T19 T18 locatedIn cDNA library,chondrocyte
R5 T23 T20 hasPart protein kinase A,subunit
R6 T30 T29 hasPart SOX9,sites
R8 T45 T47 hasPart SOX9,serine 211
R9 E16 T52 locatedIn increased,chondrocytes
R10 T57 T56 fromSpecies embryo hind legs,mouse
R11 T58 T60 hasPart Sox9,serine 211
R12 E19 T62 locatedIn localized,prehypertrophic zone
R14 E25 T78 locatedIn increased,chondrocytes
R15 T83 T82 locatedIn enhancer,chondrocyte
R16 T91 T90 hasPart SOX9,sites
R17 E32 T100 locatedIn localization,nuclear
R19 E42 T125 locatedIn signaling,growth plate
R20 T128 T127 hasFunction Sox9,activity
R21 T6 T7 hasFunction SOX9's,ability to transactivate
R3 T20 T134 hasFunction subunit,catalytic
R22 T40 T37 encodes plasmids,PKA-Calpha
R23 T40 T38 encodes plasmids,SOX9
R7 T40 T36 locatedIn plasmids,COS-7 cells
R24 T136 T137 hasPart SOX9 protein,PKA phosphorylation sites
R13 T69 T70 encodes mRNA,Col2a1
R25 T76 T141 hasFunction SOX9,activity
R26 T81 T83 hasPart Col2a1,enhancer
R27 T99 T147 hasPart SOX9,sites
R28 T114 T115 hasFunction its,transcriptional
R30 T4 E1 hasAgent protein kinase A,Phosphorylation
R31 T2 E1 hasPatient SOX9,Phosphorylation
R32 E1 E2 hasAgent Phosphorylation,enhances
R33 T7 E2 hasPatient ability to transactivate,enhances
R34 T16 E6 hasPatient Son of Sevenless,recruitment
R35 T26 E7 hasPatient SOX9,interacted
R36 T20 E7 hasPatient subunit,interacted
R37 T27 E8 hasAgent PKA,phosphorylation
R38 T29 E8 hasPatient sites,phosphorylation
R39 T32 E9 hasAgent PKA,phosphorylated
R40 T29 E9 hasPatient sites,phosphorylated
R41 T35 E10 hasAgent PKA-Calpha,phosphorylated
R42 T33 E10 hasPatient SOX9,phosphorylated
R43 T40 E11 hasPatient plasmids,expression
R44 T41 E12 hasAgent PKA,enhanced
R45 E13 E12 hasPatient phosphorylation,enhanced
R46 T44 E13 hasPatient wild-type SOX9,phosphorylation
R47 T47 E14 hasPatient serine 211,phosphorylated
R48 T48 E15 hasAgent PKA,phosphorylation
R49 T50 E15 hasPatient sites,phosphorylation
R50 T51 E16 hasAgent cAMP,increased
R51 E17 E16 hasPatient phosphorylation,increased
R52 T55 E17 hasPatient Sox9,phosphorylation
R53 T60 E18 hasPatient serine 211,phosphorylated
R54 T58 E19 hasPatient Sox9,localized
R55 T66 E20 hasPatient receptor,expression
R56 T67 E21 hasAgent cAMP,increase
R57 T69 E21 hasPatient mRNA,increase
R58 T73 E23 hasAgent PKA,phosphorylation
R59 E23 E24 hasAgent phosphorylation,modulate
R60 T141 E24 hasPatient activity,modulate
R61 T77 E25 hasAgent 8-bromo-cAMP,increased
R62 E47 E25 hasPatient activity,increased
R63 T84 E26 hasAgent PKA-Calpha,increased
R64 E48 E26 hasPatient activity,increased
R65 T90 E27 hasPatient sites,Mutations
R66 T88 E28 hasAgent PKA,phosphorylation
R67 T90 E28 hasPatient sites,phosphorylation
R68 E27 E29 hasAgent Mutations,decreased
R69 E30 E29 hasPatient activation,decreased
R70 T96 E30 hasAgent SOX9,activation
R71 T95 E30 hasPatient this enhancer,activation
R72 T97 E31 hasAgent PKA,phosphorylation
R73 T99 E32 hasPatient SOX9,localization
R74 T104 E33 hasAgent PKA,phosphorylation
R75 T103 E33 hasPatient SOX9,phosphorylation
R76 T105 E34 hasPatient DNA,binding
R77 T112 E36 hasAgent PKA,phosphorylation
R78 T111 E36 hasPatient SOX9,phosphorylation
R79 E36 E37 hasAgent phosphorylation,enhances
R80 E39 E37 hasPatient binding,enhances
R81 T114 E39 hasAgent its,binding
R82 T116 E39 hasPatient DNA,binding
R83 T121 E41 hasAgent cAMP,mediated
R84 E40 E41 hasPatient signaling,mediated
R85 T127 E43 hasPatient activity,increased
R86 E43 E44 hasAgent increased,mediate
R87 T130 E44 hasPatient PTHrP,mediate
R88 T130 E45 hasAgent PTHrP,maintaining
R89 T132 E45 hasPatient cells,maintaining
R90 T136 E3 hasPatient SOX9 protein,phosphorylation
R91 T137 E46 hasPatient PKA phosphorylation sites,mutated
R92 T83 E47 hasAgent enhancer,activity
R93 T86 E48 hasAgent this enhancer,activity
R94 T147 E49 hasPatient sites,mutations
R95 T145 E50 hasAgent PKA,phosphorylation
R96 T147 E50 hasPatient sites,phosphorylation
R97 T67 E38 hasAgent cAMP,increase
R98 T71 E38 hasPatient specific markers,increase
R99 T93 E51 hasAgent PKA-Calpha,activation
R100 T95 E51 hasPatient this enhancer,activation
R101 E36 E52 hasAgent phosphorylation,enhances
R102 T115 E52 hasPatient transcriptional,enhances
R103 E27 E53 hasAgent Mutations,decreased
R104 E51 E53 hasPatient activation,decreased

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 342-345 DiseaseOrPhenotypicFeature denotes SOS 0011604